The report highlights CanSinoBIO's commitment to ESG principles, showcasing the company's progress in areas such as business ethics, product quality, and environmental management. Key highlights include establishing an ESG Working Group, obtaining EU GMP certification for Ad5-nCoV, and achieving the one-million-hour milestone in safe construction. The report also details the company's investments in charitable initiatives, reaching RMB 5.95 million in 2021. CanSinoBIO's commitment to sustainability is evident through its various initiatives and progress made in 2021, signifying a move toward long-term growth.
Issuing Company Cansino Biologics Inc.
Report Type Sustainability Report
Report Language EN
Report Filesize 17.87 MB
No. of Pages 53 pages
Reporting periodJanuary 1, 2021-December 31, 2021
Report Edition3
Assurance Provider Unknown
Reporting Standards GRI; SASB; UNSDGs
Materiality Assessmenttrue